• Home  HOME
  • About  ABOUT US
  • About  PRODUCTS
  • Research  RESEARCH
  • Investors  INVESTOR RELATIONS
  • Contact  CONTACT
  • AFFILIATED WEBSITES
  • Contact
  •  ABOUT US
  • History
  •  PRODUCTS
  • USA
  • Canada
  • Israel
  • International
  •  INVESTOR RELATIONS
  • Investor Relations
  • Financials
  • Annual Reports
  • Fundamentals
  • Earnings & Proxy Reports
  • News Releases
  • Investor FAQ
  • E-mail Alerts
  • Contact Information
  • Safe Harbor
  • AFFILIATED WEBSITES
  • Taro Pharmaceutical Industries Ltd. Taro U.S.A
  • Taro Canada Taro Canada
  • Taro Israel Taro Israel
  • Taro International Taro International
  • Sun Pharmaceutical Ind. Ltd
  • Sun Pharmaceutical USA
  • Chattem Chemicals Inc.
Skip to main content

Taro Pharmaceutical Industries

  • WORLDWIDE SITES
      • USA
      • Canada
      • Israel
      • International
Text Size A A A

Cortoderm® , Onguent

Print Home » Cortoderm® , Onguent
Submitted by admin on Fri, 02/07/2014 - 11:24
Image: 
Principes actifs: 
Onguent d'hydrocortisone
CUP: 
063691011052
DIN: 
00716685
Format: 
15 g
Qte/caisses: 
48
Strength: 
0,5%
Product Type: 
Vente libre
Original: 
Cortate®

Category:

  • Corticostéroïde faible
  • Log in or register to post comments

Copyright © Taro Pharmaceutical Industries Ltd.  

Privacy Statement |  Terms of Use
Sitemap |  Site Credits